ダウンロード数: 1542

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
60_451.pdf820.13 kBAdobe PDF見る/開く
タイトル: 化学療法が奏功した進行性前立腺線維肉腫の1例
その他のタイトル: A Case of Advanced Prostate Fibrosarcoma that Reacted Well to Chemotherapy
著者: 横山, 仁  KAKEN_name
齋藤, 徹一  KAKEN_name
山岸, 貴裕  KAKEN_name
小川, 輝之  KAKEN_name
栗崎, 功己  KAKEN_name
加藤, 晴朗  KAKEN_name
石塚, 修  KAKEN_name
西澤, 理  KAKEN_name
著者名の別形: Yokoyama, Hitoshi
Saito, Tetsuichi
Yamagishi, Takahiro
Ogawa, Teruyuki
Kurizaki, Yoshiki
Kato, Haruaki
Ishizuka, Osamu
Nishizawa, Osamu
キーワード: Prostate sarcoma
Fibrosarcoma
Chemotherapy
発行日: Sep-2014
出版者: 泌尿器科紀要刊行会
誌名: 泌尿器科紀要
巻: 60
号: 9
開始ページ: 451
終了ページ: 454
抄録: Prostate fibrosarcoma is an extremely rare tumor for which complete excision has been the mainstay of treatment. Although chemotherapy has been attempted in cases with positive surgical margins and/or advanced stage disease, the effectiveness of this therapy has not been established. Herein, we report a case of advanced prostate fibrosarcoma that reacted well to chemotherapy. A 40-year-old man was referred for treatment of a large prostatic tumor with multiple lung, liver, and bone metastases. Needle biopsy of the prostate revealed that the tumor was a high-grade undifferentiated sarcoma. Chemotherapy with doxorubicin and ifosfamide was administered. After five courses of chemotherapy, the primary prostate tumor decreased markedly, and the lung and liver metastases almost disappeared. Radical cystoprostatectomy and ileal conduit formation were performed. Pathological diagnosis was fibrosarcoma. Another three courses of doxorubicin and ifosfamide therapy were performed, and doxorubicin was replaced by etoposide because the maximum dose of doxorubicin was reached. However, the effectiveness of the second-line therapy was poor, and the tumor progressed again. The patient died of lung metastasis 15 months later.
著作権等: 許諾条件により本文は2015/10/01に公開
URI: http://hdl.handle.net/2433/190967
PubMed ID: 25293801
出現コレクション:Vol. 60 No. 9

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。